Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery.

Alili R, Nivet-Antoine V, Saldmann A, Golmard JL, Cottart CH, Laguillier C, Giral P, Beaudeux JL, Bouillot JL, Poitou C, Clément K, Hébert-Schuster M.

Gene. 2018 May 20;656:17-21. doi: 10.1016/j.gene.2018.02.064. Epub 2018 Feb 27.

PMID:
29496557
2.

Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency.

Collet TH, Dubern B, Mokrosinski J, Connors H, Keogh JM, Mendes de Oliveira E, Henning E, Poitou-Bernert C, Oppert JM, Tounian P, Marchelli F, Alili R, Le Beyec J, Pépin D, Lacorte JM, Gottesdiener A, Bounds R, Sharma S, Folster C, Henderson B, O'Rahilly S, Stoner E, Gottesdiener K, Panaro BL, Cone RD, Clément K, Farooqi IS, Van der Ploeg LHT.

Mol Metab. 2017 Oct;6(10):1321-1329. doi: 10.1016/j.molmet.2017.06.015. Epub 2017 Jul 8.

3.

DAPK2 Downregulation Associates With Attenuated Adipocyte Autophagic Clearance in Human Obesity.

Soussi H, Reggio S, Alili R, Prado C, Mutel S, Pini M, Rouault C, Clément K, Dugail I.

Diabetes. 2015 Oct;64(10):3452-63. doi: 10.2337/db14-1933. Epub 2015 Jun 2.

4.

Bariatric Surgery Induces Disruption in Inflammatory Signaling Pathways Mediated by Immune Cells in Adipose Tissue: A RNA-Seq Study.

Poitou C, Perret C, Mathieu F, Truong V, Blum Y, Durand H, Alili R, Chelghoum N, Pelloux V, Aron-Wisnewsky J, Torcivia A, Bouillot JL, Parks BW, Ninio E, Clément K, Tiret L.

PLoS One. 2015 May 4;10(5):e0125718. doi: 10.1371/journal.pone.0125718. eCollection 2015.

5.

Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect.

Huvenne H, Le Beyec J, Pépin D, Alili R, Kherchiche PP, Jeannic E, Frelut ML, Lacorte JM, Nicolino M, Viard A, Laville M, Ledoux S, Tounian P, Poitou C, Dubern B, Clément K.

J Clin Endocrinol Metab. 2015 May;100(5):E757-66. doi: 10.1210/jc.2015-1036. Epub 2015 Mar 9.

PMID:
25751111
6.

Adipocyte ATP-binding cassette G1 promotes triglyceride storage, fat mass growth, and human obesity.

Frisdal E, Le Lay S, Hooton H, Poupel L, Olivier M, Alili R, Plengpanich W, Villard EF, Gilibert S, Lhomme M, Superville A, Miftah-Alkhair L, Chapman MJ, Dallinga-Thie GM, Venteclef N, Poitou C, Tordjman J, Lesnik P, Kontush A, Huby T, Dugail I, Clement K, Guerin M, Le Goff W.

Diabetes. 2015 Mar;64(3):840-55. doi: 10.2337/db14-0245. Epub 2014 Sep 23.

7.

Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.

Lloret-Linares C, Faucher P, Coupaye M, Alili R, Green A, Basdevant A, Clément K, Poitou C.

Int J Obes (Lond). 2013 Sep;37(9):1198-203. doi: 10.1038/ijo.2012.228. Epub 2013 Jan 15.

PMID:
23318724
8.

Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery.

Le Beyec J, Cugnet-Anceau C, Pépin D, Alili R, Cotillard A, Lacorte JM, Basdevant A, Laville M, Clément K.

J Clin Endocrinol Metab. 2013 Feb;98(2):E397-402. doi: 10.1210/jc.2012-2779. Epub 2012 Dec 28.

PMID:
23275530
9.

Valsartan improves adipose tissue function in humans with impaired glucose metabolism: a randomized placebo-controlled double-blind trial.

Goossens GH, Moors CC, van der Zijl NJ, Venteclef N, Alili R, Jocken JW, Essers Y, Cleutjens JP, Clément K, Diamant M, Blaak EE.

PLoS One. 2012;7(6):e39930. doi: 10.1371/journal.pone.0039930. Epub 2012 Jun 29.

10.

Association between CST3 rs2424577 polymorphism and corpulence related phenotypes during lifetime in populations of European ancestry.

Hooton H, Dubern B, Henegar C, Paternoster L, Nohr EA, Alili R, Rousseau F, Pelloux V, Galan P, Hercberg S, Arner P, Sørensen TI, Clément K.

Obes Facts. 2011;4(2):131-44. doi: 10.1159/000327797. Epub 2011 Apr 15.

11.

Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss.

Kim MJ, Marchand P, Henegar C, Antignac JP, Alili R, Poitou C, Bouillot JL, Basdevant A, Le Bizec B, Barouki R, Clément K.

Environ Health Perspect. 2011 Mar;119(3):377-83. doi: 10.1289/ehp.1002848. Epub 2010 Dec 15.

12.

Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity.

Mencarelli M, Dubern B, Alili R, Maestrini S, Benajiba L, Tagliaferri M, Galan P, Rinaldi M, Simon C, Tounian P, Hercberg S, Liuzzi A, Di Blasio AM, Clement K.

Hum Mol Genet. 2011 Jan 15;20(2):392-9. doi: 10.1093/hmg/ddq472. Epub 2010 Nov 3.

PMID:
21047972
13.

NHERF1 mutations and responsiveness of renal parathyroid hormone.

Karim Z, Gérard B, Bakouh N, Alili R, Leroy C, Beck L, Silve C, Planelles G, Urena-Torres P, Grandchamp B, Friedlander G, Prié D.

N Engl J Med. 2008 Sep 11;359(11):1128-35. doi: 10.1056/NEJMoa0802836.

14.

Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach.

Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, Friedlander G, Terzi F.

Nat Med. 2005 Aug;11(8):867-74. Epub 2005 Jul 24.

PMID:
16041383

Supplemental Content

Support Center